Coloplast is a global manufacturer of intimate healthcare products and a market leader in ostomy, continence care, and voice and respiratory care, while holding smaller positions in wound care and interventional urology.
Coloplast's dominant position in ostomy and continence care is built on decades of innovation and customer relationships that are difficult to replicate and supports both pricing resilience and long-term customer retention.
Bears
With the majority of revenue subject to third-party reimbursement, Coloplast is structurally exposed to healthcare cost containment—most concretely illustrated by the anticipated introduction of Medicare competitive bidding in the US from 2028 onward.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.